Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%
Latest executive order could shake up US pharma industry
Move comes as government seeks to boost UK’s standing as drugs research leader
A Leicester hospital is trialling a fresh approach to caring for older patients as demographic shifts loom
Poor training and lack of investment are main challenges to successful deployment, says think-tank
Sale of US healthcare software company grants two-fold return on investment
Announcement follows recommendation in UK government-commissioned review last year
Healthcare workers and officials say falsehoods and conspiracy theories cost lives and are exacerbating inequalities
Under the scheme, drugmakers discount price of medicines sold in bulk to healthcare system
Medical devices maker to discuss options for $21bn division with Thermo Fisher, Danaher and other smaller rivals
European countries offer England evidence of how to navigate seasonal strains without big disruption to services
In many places where Trump is hugely popular, residents are increasingly reliant on state income transfers. The issue could fracture the Republican party
Lack of incentives is driving down the number of clinical researchers in Britain
Machine makes 3D scans of the digestive system, which could improve early diagnosis for the second-deadliest cancer
Once researchers begin wondering whether their government might pull the rug from under them, the damage is done
Declining availability highlights challenges for sector
Chief executive says most car buyers come from households on incomes of less than £20,000
Senate report on one hospital finds that PE debt can lead to a cycle of under-investment
The health benefits could be so extreme that it upends the annuity market, hitting retirement incomes and insurers
Investment funds have been looking to offload assets in a push to realise returns
Experts say there are regional disparities in medication access even as prescriptions rise
Streeting will find the buck stops with him on the worst challenge of all: the funding crisis
Purpose and prospects rank ahead of pay, though higher wages would improve satisfaction
Reforms rather than quick fixes will save more money in the long term
Buyout of group behind Boots will bring to an end the drugstore chain’s century-long run as a public company
